scholarly article | Q13442814 |
P2093 | author name string | Chin-Fu Chen | |
Chao-Chien Hu | |||
Hsia-Wei Liu | |||
Jen-Ray Chaw | |||
Yin-Chen Chiu | |||
P2860 | cites work | Ranibizumab and bevacizumab for neovascular age-related macular degeneration | Q24616209 |
Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results | Q24633874 | ||
Injectable biodegradable temperature-responsive PLGA-PEG-PLGA copolymers: synthesis and effect of copolymer composition on the drug release from the copolymer-based hydrogels | Q30986623 | ||
Expression of cytokines and transcription factors in photocoagulated human retinal pigment epithelial cells | Q30990451 | ||
Multiple laser treatments for macular edema attributable to branch retinal vein occlusion | Q33213626 | ||
Thermo-responsive chitosan-graft-poly(N-isopropylacrylamide) injectable hydrogel for cultivation of chondrocytes and meniscus cells. | Q51100401 | ||
Six-month stability of bevacizumab (Avastin) binding to vascular endothelial growth factor after withdrawal into a syringe and refrigeration or freezing. | Q51182085 | ||
Controlled release bevacizumab in thermoresponsive hydrogel found to inhibit angiogenesis. | Q53444034 | ||
Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. | Q53599948 | ||
Diabetic retinopathy | Q75217418 | ||
Pharmacokinetics of intravitreal bevacizumab (Avastin) | Q80235081 | ||
Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1 | Q80553646 | ||
Upregulation of VEGF in murine retina via monocyte recruitment after retinal scatter laser photocoagulation. | Q33308452 | ||
Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells | Q34047111 | ||
Click hydrogels, microgels and nanogels: emerging platforms for drug delivery and tissue engineering. | Q38199837 | ||
Extended release of bevacizumab by thermosensitive biodegradable and biocompatible hydrogel | Q39432443 | ||
PEGDA hydrogels with patterned elasticity: Novel tools for the study of cell response to substrate rigidity | Q39789474 | ||
Hydrophobically modified biodegradable poly(ethylene glycol) copolymers that form temperature-responsive Nanogels | Q43286422 | ||
Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study | Q46528410 | ||
Intravitreal bevacizumab for treatment of neovascular age-related macular degeneration: a one-year prospective study. | Q46859579 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | S1 | |
P921 | main subject | angiogenesis | Q539568 |
hydrogel | Q898925 | ||
drug delivery | Q1392806 | ||
P304 | page(s) | 153-163 | |
P577 | publication date | 2019-01-01 | |
P1433 | published in | Technology and Health Care | Q22030355 |
P1476 | title | Thermo-responsive hydrogel as an anti-VEGF drug delivery system to inhibit retinal angiogenesis in Rex rabbits | |
P478 | volume | 27 |
Search more.